Safety gates are fail-closed. Contraindication and interaction checks run before a prescription is signed, and again as the record changes. The provider, not the software, makes every clinical decision.
“Most of us know very little about peptides outside of GLPs. Having something that analyzes data and suggests protocols with safety guardrails is tremendous value.”
On the patient side, Aura™ translates the approved plan into daily guidance grounded in the patient's own record.